Abvc Biopharma ABVC
NASDAQ ABVC
$1.01 -0.01 (-0.98%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Abvc Biopharma's Return on Capital Employed [ROCE] was -46.97% in Q2 2026, down 2.71 percentage points from -44.26% a year earlier but up 6.56 percentage points from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Abvc Biopharma came in at -87.88%, up 338.03 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +104.43 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -425.91% in FY2024 (-163.65 pp), -262.26% in FY2023 (-14.29 pp), -247.97% in FY2022 (-117.33 pp) and -130.65% in FY2021 (+61.67 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -452.19% (Q1 2024) and -44.26% (Q2 2025) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in five of the last eight quarters, with an average year-over-year change of +106.66 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2021 (a gain of 957.59 percentage points); the worst was Q4 2024 (a drop of 316.04 percentage points).
  • Per Business Quant data, ABVC's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -53.52% (Q1 2026), -47.76% (Q4 2025) and -46.43% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Abvc Biopharma 26.03 Mn 28.01 Mn - -46.97%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46.97%
Mar 31, 2026 -53.52%
Dec 31, 2025 -47.76%
Sep 30, 2025 -46.43%
Jun 30, 2025 -44.26%
Mar 31, 2025 -57.18%
Dec 31, 2024 -427.23%
Sep 30, 2024 -271.16%
Jun 30, 2024 -360.97%
Mar 31, 2024 -452.19%
Dec 31, 2023 -111.18%
Sep 30, 2023 -123.64%
Jun 30, 2023 -257.33%
Mar 31, 2023 -212.54%
Dec 31, 2022 -336.89%
Sep 30, 2022 -223.72%
Jun 30, 2022 -179.80%
Mar 31, 2022 -180.85%
Dec 31, 2021 -125.41%
Sep 30, 2021 -140.19%
API Access

Abvc Biopharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEY